logo
  

Bloomberg: Sinopec Working With Goldman Sachs For $30 Bln Unit Sale

China Petroleum & Chemical Corp. (SNPMF.OB,SNP), popularly known as Sinopec, is working with Goldman Sachs Group Inc. (GS) on the sale of a stake in its retail assets, Bloomberg reported quoting people with knowledge of the matter.

Sinopec could raise as much as $30 billion by selling a 30 percent stake in its retail unit. The unit includes China's biggest network of fuel stations. Such a deal will be the biggest asset sale by a Chinese state-owned company.

China International Capital Corp. is also said to be advising Sinopec on asset restructuring across the group. Sinopec has more than 30,000 fuel stations.

The decision to offload assets comes after Premier Li Keqiang decided to infuse non-state capital in oil and power projects and accelerate development of mixed-ownership firms.

Chinese energy giants such as Sinopec and PetroChina Co. earn less on investments or have lower stock market returns than their peers in the West.

SNP closed down 0.14 percent on Wednesday at $90.17.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
RELATED NEWS
Follow RTT